Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06118463
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-31
Brief Title:
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Sponsor:
Lin Yuan
Organization:
Qianfoshan Hospital
Study Overview
Official Title:
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To detect the expression of AUNIP in cervical cancer serum and to clarify its diagnostic and prognostic value
Detailed Description:
Blood of all study participants of cervical cancer patients are collected to detect the expression of AUNIP analyze the statistical correlation between the expression of cervical cancer AUNIP and clinicopathological parameters of patients and preliminarily understand the expression of AUNIP in cervical cancer tumor tissues and its clinical diagnostic and progniostic value
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None